Abbott Laboratories, a multinational health care and medical device company, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making history as the first ever handheld blood test for traumatic brain injuries (TBIs). The innovative treatment will help doctors diagnose and assess patients suspected of having TBIs by taking their blood plasma, putting it on the test cartridge, and running it on Abbott’s handheld i-STAT™ Alinity™ platform. The results are available within 15 minutes after insertion.
Read more here.
More on: News Regulatory